Navigation Links
EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
Date:4/9/2008

MD-1198, a novel antimitotic agent, and ENMD-2076, a selective kinase inhibitor, are in Phase 1 studies in advanced cancers. The Company also has an approved IND application for Panzem(R) in rheumatoid arthritis. EntreMed's goal is to develop and commercialize new compounds based on the Company's expertise in angiogenesis, cell-cycle regulation and inflammation -- processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. Additional information about EntreMed is available on the Company's web site at http://www.entremed.com and in various filings with the Securities and Exchange Commission.

Forward Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance (including the timing of royalty revenues and future R&D expenditures), strategies, expectations and goals. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed. Actual results could differ materially from those currently anticipated due to a number of factors, including those set forth in Securities and Exchange Commission filings under "Risk Factors," including risks relating to the need for additional capital and the uncertainty of additional funding; variations in actual sales of Thalomid(R), risks associated with the Company's product candidates; the early-stage products under development; results in preclinical models are not necessarily indicative of clinical results, uncertainties relating to preclinical and clinical trials; success in the clinical development of any products; dependence on third parties; future capital needs; and risks relating to the commerci
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
2. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
3. EntreMed to Present at The New York Society of Security Analysts Industry Conference
4. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
5. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
6. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
7. EntreMed Raises $20 Million to Support Clinical Development Program
8. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
9. Bionomics Achieves US$1 Million Milestone Payment from Genmab
10. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
11. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... , April 24, 2015 Allowing more ... could reduce drug overdose deaths that involve opioids, according ... study, "Disparity in Naloxone Administration by Emergency Medical Service ... Communities," published in the American Journal of Public ... deaths in the United States ...
(Date:4/24/2015)...  IGI Laboratories, Inc. (NYSE MKT: IG), a ... company, announced the Company will hold a conference call ... to discuss the 1st quarter 2015 results. ... by dialing 1-888-346-3479. International participants should call 1-412-902-4260. Canadian ... joined into the IGI Laboratories, Inc. call. ...
(Date:4/24/2015)... , April 24, 2015   Vestagen Technical ... technology, VESTEX ® , has recently received two notable ... a global competition that recognizes innovations with potential to ... ceremony last night in New York City ... the Material Science "Protection & Safety" category. The awards ...
Breaking Medicine Technology:Expanding Naloxone use could reduce drug overdose deaths and save lives 2Expanding Naloxone use could reduce drug overdose deaths and save lives 3VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 2VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 3
(Date:4/24/2015)... 2015 As the nation recognizes the ... sacrifices of these young men and women, the “Alaska ... and their Families” presents a special training session on ... gain a better understanding of the effect of childhood ... those – civilian and military – who provide services ...
(Date:4/24/2015)... 24, 2015 The 1975 have ... constantly across the globe to theaters, festivals and TV performances. ... they’ve partnered with their label, Dirty Hit Records, to provide ... with the newly launched Cadence & Cause website, ... LP on vinyl and a signed photo card. Entries ...
(Date:4/24/2015)... 24, 2015 Anchor Health Administrators (Anchor), ... Professionals, today announced their exclusive agreement with LTC Solutions ... Care Insurance distribution partner. , Anchor has more than ... Insurance benefits for associations, and is currently the designated ... Long Term Care Insurance member benefit. , “I am ...
(Date:4/24/2015)... 24, 2015 Insuranceautoquote.info has released a ... insurance premiums . , Lowering auto insurance prices ... to simply find better offers for their financial budget. ... it does not require any registration. , Comparing ... There are multiple agencies that sell coverage and this ...
(Date:4/24/2015)... 24, 2015 Telematics Berlin is the ... tier 1 & 2 suppliers, content providers, associations and ... in the value chain, see them converge in Berlin. ... only hear from those companies currently at the forefront ... partners. Working on customer centric products, ParkTAG are one ...
Breaking Medicine News(10 mins):Health News:Coalition Presents Resiliency Training to Raise Awareness during Month of the Military Child (#MOTMC2015) 2Health News:Internationally Recognized British Indie Rock Outfit The 1975 Partner with Cadence & Cause to Provide Clean Drinking Water to Those in Need 2Health News:Car Insurance Quotes Can Help Drivers Lower Their Premiums 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 2Health News:Telematics Berlin 2015’s inaugural European Automotive Start-Up Competition 3
... Cardium Therapeutics,(NYSE Alternext: CXM) and its operating ... adoption of procedures designed to promote,temperature modulation therapy ... in The New York Times . ... 2008, reports that New York City ambulances will ...
... today,announced that its employees committed more than $1 million ... This amount is the,result of personal giving by associates ... , "In this ... in need of help," said Mark Wagar, president and,CEO ...
... Seniors, Access to Quality Care, LTC Jobs Base , ... Commenting on the legislative year ahead as well as the ... nursing facilities (SNFs) should not receive a market basket cost ... term care advocacy organizations today said the sector supports and ...
... controls for intravenous use, standardization of practices , , FRIDAY, ... their own pain medication intravenously is four times more ... a new study says. , The report, ... Commission Journal on Quality and Patient Safety , shows ...
... Systems (NYSE: VAR ) announced today that its Board ... for February 12, 2009 with a record date of December 15, ... 4290 El Camino Real, Palo Alto, California at 4:30 p.m. PT. ... webcast by Thomson Financial and can be accessed at Varian Medical ...
... LLC, creator,of the Sensible Portions brand, is teaming with the ... the IZOD CENTER. , ... Nets are recognizing the,need to provide fans with healthier in-game ... Crisps, which are,baked, all natural, and contain no trans fat, ...
Cached Medicine News:Health News:Cardium Reports on New York City's Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients 2Health News:Cardium Reports on New York City's Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients 3Health News:Cardium Reports on New York City's Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients 4Health News:Cardium Reports on New York City's Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients 5Health News:Cardium Reports on New York City's Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients 6Health News:Cardium Reports on New York City's Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients 7Health News:Cardium Reports on New York City's Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients 8Health News:Cardium Reports on New York City's Adoption of Therapeutic Cooling Protocols for Cardiac Arrest Patients 9Health News:Empire BlueCross BlueShield Associates Commit Over $1 Million to Community Organizations in 2008 2Health News:Long Term Care Sector Supports and Is Well-Positioned to Advance Health Care Reform, Bolster Economic Stimulus 2Health News:Long Term Care Sector Supports and Is Well-Positioned to Advance Health Care Reform, Bolster Economic Stimulus 3Health News:Self-Dosing Pain Medication Errors Too Common: Study 2Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:Nets Provide Fans with Healthy In-Game Snack Option 2
... cassettes, 4 fiber pads, modular electrode assembly, ... with cables, and instructions. The Mini ... mini electrophoresis system (see Mini-Vertical Electrophoresis Systems), ... Its modular electrode assembly transfers two 7.5 ...
... PowerPac 200 power supply. ... Parameters. Quantitative Transfers. Native ... Transfers. Faster, Higher-Efficiency Transfers ... Field-Intensity Transfers with Movable Electrodes. ...
... holder cassettes, cell with lid ... blot absorbent paper (15 x ... cell, used with the PowerPac ... high-intensity electrophoretic transfers. The Trans-Blot ...
... running Criterion precast gels and Criterion ... fit for use with the incredible ... Criterion blotter combines excellent blotting efficiency ... system and the ease-of-use of the ...
Medicine Products: